Examining the promise of HIV elimination by ‘test and treat’ in hyperendemic settings
Top Cited Papers
Open Access
- 13 March 2010
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 24 (5), 729-735
- https://doi.org/10.1097/qad.0b013e32833433fe
Abstract
Background: It has been suggested that a new strategy for HIV prevention, ‘Universal Test and Treat’, whereby everyone is tested for HIV once a year and treated immediately with antiretroviral therapy (ART) if they are infected, could ‘eliminate’ the epidemic and reduce ART costs in the long term. Methods: We investigated the impact of test-and-treat interventions under a variety of assumptions about the epidemic using a deterministic mathematical model. Results: Our model shows that such an intervention can substantially reduce HIV transmission, but that impact depends crucially on the epidemiological context; in some situations, less aggressive interventions achieve the same results, whereas in others, the proposed intervention reduces HIV by much less. It follows that testing every year and treating immediately is not necessarily the most cost-efficient strategy. We also show that a test-and-treat intervention that does not reach full implementation or coverage could, perversely, increase long-term ART costs. Conclusion: Interventions that prevent new infections through ART scale-up may hold substantial promise. However, as plans move forward, careful consideration should be given to the nature of the epidemic and the potential for perverse outcomes.Keywords
This publication has 47 references indexed in Scilit:
- Patterns of Self-reported Behaviour Change Associated with Receiving Voluntary Counselling and Testing in a Longitudinal Study from Manicaland, ZimbabweAIDS and Behavior, 2009
- Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studiesThe Lancet, 2009
- Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical modelThe Lancet, 2009
- Duration from seroconversion to eligibility for antiretroviral therapy and from ART eligibility to death in adult HIV-infected patients from low and middle-income countries: collaborative analysis of prospective studiesSexually Transmitted Infections, 2008
- Persisting with prevention: The importance of adherence for HIV preventionEmerging Themes in Epidemiology, 2008
- Reassessing HIV PreventionScience, 2008
- Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in MalawiThe Lancet, 2008
- Effect of Herpes Simplex Suppression on Incidence of HIV among Women in TanzaniaNew England Journal of Medicine, 2008
- Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trialThe Lancet, 2007
- HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countriesBMC Health Services Research, 2007